ALDH1+ CSCs downregulate the TAP gene and CD80, thereby targeting the antigen presentation pathway (84), while the CD44+/CD24− group upregulates the expression of CXCR4 which is involved in EMT and the induction of the CSC phenotype in BC (83, 85, 86). This evidence concerns the gene ALDH1A1 and breast cancer.